Patent · US Active

Highly pure pentamycin

US9090582B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

Biolotus Biotechnology AG · CH

Inventors

Karl Reuter · Gundelfingen, DE
Victor Meier · Gundelfingen, DE
Florian Stolz · Glückstadt, DE
Dieter Krimmer · Zug, CH
Cees Winninps · Fluh, CH

Key dates

Filing date	Jul 22, 2013
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Jul 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H17/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described is pentamycin in a purity exceeding 95%, certain polymorphs and solvates of pentamycin, processes for their manufacture, and a method for decreasing the rate of degradation of pentamycin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.